Prokidney (PROK) Research & Development (2021 - 2026)

Prokidney (PROK) has reported Research & Development for 6 consecutive years, with $36.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 39.46% year-over-year to $36.1 million in Q2 2026; TTM through Jun 2026 was $130.9 million, a 5.43% increase from a year earlier, with the FY2025 full-year figure at $114.1 million, down 10.61% from the prior year.
• Research & Development was $36.1 million for Q2 2026 at Prokidney, up from $33.8 million in the prior quarter.
• Over five years, Research & Development peaked at $39.8 million in Q4 2024 and troughed at $11.6 million in Q2 2022.
• A 5-year average of $27.8 million and a median of $27.2 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development surged 128.1% in 2023 and decreased 14.17% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $20.9 million in 2022, then increased by 7.84% to $22.5 million in 2023, then jumped by 76.58% to $39.8 million in 2024, then slipped by 14.14% to $34.2 million in 2025, then grew by 5.67% to $36.1 million in 2026.
• The last three Research & Development figures came in at $36.1 million (Q2 2026), $33.8 million (Q1 2026), and $34.2 million (Q4 2025), per Business Quant data.